-
Mashup Score: 0Opinion | José Andrés: Let People Eat - 1 month(s) ago
You cannot win this war by starving an entire population.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 112Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy - 3 month(s) ago
Bispecific antibodies (BsAb) that target CD3 and CD20 represent a new milestone in the treatment of patients with B-cell non-Hodgkin lymphoma. These drugs have
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 105Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy - 3 month(s) ago
Bispecific antibodies (BsAb) that target CD3 and CD20 represent a new milestone in the treatment of patients with B-cell non-Hodgkin lymphoma. These drugs have
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More - 11 month(s) ago
In this story, an expert in the gut microbiome answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Fluent in the Language of Style - 1 year(s) ago
For over three decades, Judith Thurman has captured the often ineffable pull of fashion and beauty like few others.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Nel 2018 ha ricevuto il premio per essere riuscito a scatenare una reazione immuntaria contro i melanomi. Sul palco del Festival di Salute racconta come centin…
Source: la RepubblicaCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 139Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies - 2 year(s) ago
CD19-targeted chimeric antigen receptor (CD19 CAR) T cells have efficacy for relapsed/refractory B-cell malignancies, but relapses occur in a high percentage of
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells - 2 year(s) ago
TO THE EDITOR:
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 60Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms - 2 year(s) ago
Key Points. Exposure to thalidomide analogs, particularly lenalidomide, is associated with increased risk of TP53-mutated myeloid neoplasmsTreatment with lenali
Source: American Society of HematologyCategories: Latest Headlines, Oncologists1Tweet
via @NYTOpinion https://t.co/3kRijBAvrS